226 related articles for article (PubMed ID: 31604807)
1. Sampling Site Has a Critical Impact on Physiologically Based Pharmacokinetic Modeling.
Huang W; Isoherranen N
J Pharmacol Exp Ther; 2020 Jan; 372(1):30-45. PubMed ID: 31604807
[TBL] [Abstract][Full Text] [Related]
2. Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site.
Musther H; Gill KL; Chetty M; Rostami-Hodjegan A; Rowland M; Jamei M
AAPS J; 2015 Sep; 17(5):1268-79. PubMed ID: 26100012
[TBL] [Abstract][Full Text] [Related]
3. Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling.
Shum S; Shen DD; Isoherranen N
Drug Metab Dispos; 2021 Nov; 49(11):1003-1015. PubMed ID: 34407992
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
Peters SA
Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
[TBL] [Abstract][Full Text] [Related]
5. Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.
Björkman S
J Pharmacokinet Pharmacodyn; 2003 Aug; 30(4):285-307. PubMed ID: 14650375
[TBL] [Abstract][Full Text] [Related]
6. Combined Recirculatory-compartmental Population Pharmacokinetic Modeling of Arterial and Venous Plasma S(+) and R(-) Ketamine Concentrations.
Henthorn TK; Avram MJ; Dahan A; Gustafsson LL; Persson J; Krejcie TC; Olofsen E
Anesthesiology; 2018 Aug; 129(2):260-270. PubMed ID: 29771709
[TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.
Boger E; Fridén M
J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860
[TBL] [Abstract][Full Text] [Related]
8. Physiologically-based pharmacokinetic model for Fentanyl in support of the development of Provisional Advisory Levels.
Shankaran H; Adeshina F; Teeguarden JG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):464-76. PubMed ID: 23732079
[TBL] [Abstract][Full Text] [Related]
9. Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling.
Li GF; Wang K; Chen R; Zhao HR; Yang J; Zheng QS
Acta Pharmacol Sin; 2012 Nov; 33(11):1359-71. PubMed ID: 23085739
[TBL] [Abstract][Full Text] [Related]
10. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
[TBL] [Abstract][Full Text] [Related]
11. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
[TBL] [Abstract][Full Text] [Related]
12. A Bottom-Up Whole-Body Physiologically Based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins.
Gill KL; Gardner I; Li L; Jamei M
AAPS J; 2016 Jan; 18(1):156-70. PubMed ID: 26408308
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.
Levitt DG
BMC Clin Pharmacol; 2004 Feb; 4():2. PubMed ID: 15053829
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
Edginton AN; Schmitt W; Willmann S
Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
[TBL] [Abstract][Full Text] [Related]
15. Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model.
Ladumor MK; Unadkat JD
Drug Metab Dispos; 2022 May; 50(5):519-528. PubMed ID: 35246463
[TBL] [Abstract][Full Text] [Related]
16. Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.
Pan S; Duffull SB
J Pharmacokinet Pharmacodyn; 2019 Aug; 46(4):361-370. PubMed ID: 31227954
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the Impact of Partition Coefficient Prediction Methods on Physiologically Based Pharmacokinetic Model Output Using a Standardized Tissue Composition.
Utsey K; Gastonguay MS; Russell S; Freling R; Riggs MM; Elmokadem A
Drug Metab Dispos; 2020 Oct; 48(10):903-916. PubMed ID: 32665416
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine.
Huang W; Czuba LC; Isoherranen N
J Pharmacol Exp Ther; 2020 Jun; 373(3):488-501. PubMed ID: 32198137
[TBL] [Abstract][Full Text] [Related]
19. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.
Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P
Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326
[TBL] [Abstract][Full Text] [Related]
20. Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients.
Kovar L; Weber A; Zemlin M; Kohl Y; Bals R; Meibohm B; Selzer D; Lehr T
Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32977559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
